(Press-News.org) (MIAMI, FL, FEB. 21, 2023) – To create the most effective, personalized treatment plans for patients with Hodgkin lymphoma or other cancers, scientists and clinicians need the clearest picture of the genetic changes leading to the cancer’s development. That picture, say scientists at Sylvester Comprehensive Cancer Center in the University of Miami Miller School of Medicine, comes into much better focus when whole genome sequencing – rather than the current standard, exome sequencing – is used to identify changes driving the cancer.
Exome sequencing, which reads only protein-coding genes, can detect some specific mutations and other variants that propel cancers, but the multicenter team led by researchers at Sylvester and other cancer research centers found that whole genome sequencing (WGS) can read virtually all the mutations in both protein-coding and noncoding regions of the genome, and it can detect other changes that can lead to cancer’s development.
“We found many genomic events that had never been recorded before. It’s the best technology we’ve found to identify new cancer drivers,” said Dr. Craig Moskowitz, physician-in-chief, Oncology Service Line at Sylvester, professor of medicine at the Miller School and a co-author of an article published in Blood Cancer Discovery.
While exome sequencing has been extremely fruitful, detecting point mutations and other variants that propel cancers, it paints an incomplete picture. Mutations in noncoding genomic regions can also govern gene expression. In addition, WGS identifies a wide range of structural variations, including chromothripsis, in which damaged chromosomes look like they’ve been hit by sledgehammers.
The study identified many of these issues in cHL, as well as finding mutational signatures associated with chemotherapy. Perhaps most importantly, WGS provided temporal insights into how the cancers evolved. Reconstructing tumor chronology could play a major role in treatment selection.
“It’s important to know how a tumor developed over time,” said Dr. Francesco Maura, co-leader of the Myeloma Genomic Lab at Sylvester, assistant professor of medicine, and first author of the study. “We need to know which mutations were acquired and in what order. If we prescribe a targeted therapy, we want it to target genomic alterations that are shared throughout the tumor, rather than the subclones that came later and are relatively rare.”
For this proof-of-concept study, the researchers invented a sophisticated system making it possible to isolate and study the rare Hodgkin and Reed Sternberg cells found in classic Hodgkin lymphoma (cHL). They believe this approach, combined with WGS, could provide many new insights into cHL and other cancers.
“Cancers are incredibly complex diseases, and we still have a long way to go before we fully understand them,” said C. Ola Landgren, M.D., director of the Myeloma Research Institute, co-leader of Translational and Clinical Oncology Research Program, and co-author on the study. “By leveraging WGS, we can better assess tumor evolution, identify structural issues and hopefully gain new therapeutic insights.”
The research was led by scientists from Sylvester, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College.
This work was supported by the Children’s Oncology Group, the Hartwell Foundation, the Gant Family Foundation, the Sylvester Comprehensive Cancer Center NCI Core Grant (P30 CA 240139), and the Memorial Sloan Kettering Cancer Center NCI Core Grant (P30 CA 008748). Maura is supported by the American Society of Hematology. Maura and Landgren are supported by the Riney Family Foundation. Lisa Giulino-Roth, M.D., a co-author, is supported by the NIH (K08CA219473), The Gant Family Foundation, and The Hartwell Foundation.
Disclosures/Possible Conflict of Interest: A senior author, from Weill Cornell, is a scientific advisory board member at Merck. Other authors do not have conflicts of interest to declare.
Sylvester Comprehensive Cancer Center, part of UHealth — University of Miami Health System and the University of Miami Miller School of Medicine, is the only National Cancer Institute (NCI)-designated and nationally ranked cancer center in South Florida, according to U.S. News & World Report 2022-2023 Best Hospitals for Cancer. NCI designation is the "gold standard" for cancer centers and recognizes that Sylvester has met the most rigorous standards for cancer research, beginning in our laboratories, extending to patient care, and addressing specific needs in our community. It also offers a Phase 1 clinical trials program – the first step in evaluating how patients respond to the latest investigational treatments. Equipped with a highly qualified team of nearly 2,500 cancer-focused physicians, researchers, and support staff working together, Sylvester discovers, develops, and delivers more precision cancer care. To serve current and future patients, Sylvester has a network of 10 conveniently located outpatient treatment facilities throughout South Florida.
DOI: 10.1158/2643-3230.BCD-22-0128
Link to Sylvester Newsroom article.
# # #
END
Written by Kay Ledbetter, 806-547-0002, skledbetter@ag.tamu.edu
Imagine your favorite cured meat like beef jerky, pepperoni or bacon without any added sodium nitrite from any source currently necessary for color and shelf life. Wes Osburn, Ph.D., is doing exactly that.
At center, Wes Osburn, Ph.D., Texas A&M University meat scientist, is working in his lab with students Tanner Wright and Arlie Reeves on a new no nitrite-added cured meat system. (Texas A&M AgriLife photo ...
Eurasian spruce bark beetles (Ips typographus) burrow into the bark of Norway spruce (Picea abies) trees where they mate and lay their eggs. Major outbreaks in Europe have decimated millions of hectares of conifer forests. The beetles preferentially attack trees that are already infected with symbiotic fungi (such as Grosmannia penicillata), which is thought to weaken host trees and break down their chemical defenses, allowing the beetles to successfully develop in the bark.
To investigate the chemical signals ...
The mass outbreaks of bark beetles observed in recent years have caused shocking amounts of forest damage throughout Germany. As reported by the Federal Statistical Office in July 2022, more than 80% of the trees that had to be felled in the previous year were damaged by insects. The damaged timber felled due to insect damage amounted to more than 40 million cubic meters. One of the main pests is the European spruce beetle Ips typographus. In the Thuringian Forest and the Harz Mountains, for example, the beetle, which is only a few millimeters long, encountered spruce monocultures that had already been weakened by high temperatures and extended ...
Takeaki Ozawa and his team from the University of Tokyo reveal the metabolic reactions upon activating an enzyme called Akt2. In doing so, they reveal the inner workings of insulin-regulated metabolism. The findings lead the way for Akt2-targeting therapeutics for diabetes and metabolic disorders.
It takes energy to do anything—even to exist. You can metabolize food to convert glucose into energy: thanks to many cascades of molecular reactions within your cells. As soon as you eat, your pancreas secretes insulin hormone, which starts ...
SAN FRANCISCO, CA—February 21, 2023—Of all the known genetic risk factors for late-onset Alzheimer’s disease, the strongest is a gene for the protein called ApoE4. People with one copy of this gene are 3.5 times more likely, on average, to develop Alzheimer’s than others, and those with two copies face a 12-fold increased risk. However, exactly how ApoE4 boosts the risk of Alzheimer’s remains unclear.
Multiple types of cells in the brain make ApoE4—some of it is produced by neurons, but other brain cells called glia make it in higher quantities. For that reason, most prior research on this protein has focused on ...
University Professor Douglas Rhoads has been named a Fellow of the American Association for the Advancement of Science, the world’s largest general scientific society and publisher of the journal Science.
As one of only 20 fellows representing the Section on Agriculture, Food & Renewable Resources, Rhoads was chosen by his peers and colleagues for advancing science and its applications in service to society. The organization elected a total of 505 fellows across 24 scientific sections.
Rhoads is director of the Interdisciplinary ...
Researchers from Oregon Health & Science University and institutions across the country have identified a pill used to treat a common skin disease as an “incredibly promising” treatment for alcohol use disorder.
The study was recently published in the Journal of Clinical Investigation.
On average, the people who received the medication, called apremilast, reduced their alcohol intake by more than half — from five drinks per day to two.
“I’ve never seen anything like that before,” said co-senior author Angela Ozburn, Ph.D., associate professor of behavioral neuroscience in the OHSU School of Medicine and a research biologist ...
The University of Ottawa's Dr. Mamta Gautam is the first awardee of the AFMC Wellness Award, a new national honour that recognizes an individual in Canada who has shown dedication to the promotion and advancement of the wellness of physicians, medical students, and others.
“I am truly humbled and honoured. Promoting physician wellbeing is an area that I have been passionate about for over 30 years. To have the AFMC create an award to recognize contributions in this area lends further credibility to the importance of this topic,” ...
A solar radio burst with a signal pattern, akin to that of a heartbeat, has been pinpointed in the Sun’s atmosphere, according to a new study.
In findings published in the journal Nature Communications, an international team of researchers has reported uncovering the source location of a radio signal coming from within a C-class solar flare more than 5,000 kilometers above the Sun’s surface.
Researchers say the study’s findings could help scientists better understand the physical processes behind the energy release of solar flares — the solar system’s most powerful explosions.
“The ...
Huntsman Cancer Institute at the University of Utah (The U) is pleased to congratulate three of our newest endowed chairs. A chair appointment recognizes excellence, while providing academic distinction and funding for future research. Alana Welm, PhD, received a five-year extension in her current role as Ralph E. and Willia T. Main Presidential Endowed Chair in Cancer Research, Aik Choon Tan, PhD, was named the Jon and Karen Huntsman Presidential Professor in Cancer Research, and Brad Cairns, PhD, was named ...
